The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways - Concepedia

Concepedia

Publication | Open Access

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

DOI Full Paper Access

509

Citations

43

References

2003

Year

Mark J. Millan, Alain P. Gobert, F. Lejeune, A Dekeyne, Adrian Newman‐Tancredi, Valérie Pasteau, Jean‐Michel Rivet, Didier Cussac

Journal of Pharmacology and Experimental Therapeutics

References

	Year	Citations

Page 1